Results 151 to 160 of about 213,120 (197)

Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection. [PDF]

Acta Pharm Sin B
Ma C, Chang J, Yu B.
europepmc   +1 more source

Human Adipose Tissue 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Without Tachyphylaxis by Clofutriben, a Pseudo-Irreversible Enzyme Inhibitor. [PDF]

Clin Transl Sci
An G, Gutierrez JA, Abad-Zapatero C, Lin SK, Schmicker C, Rinas A, Engel B, Magers T, Marmon TK, Katz DA.   +9 more
europepmc   +1 more source

A highly potent human antibody neutralizing all serotypes of BK polyomavirus. [PDF]

PLoS Pathog
Weber M, Schmitt S, Eicher B, Seidenberg J, Rutkauskaite J, Stöckli B, Townsend C, Huynh-Do U, Schachtner T, Delbue S, Mäder A, Esslinger C, Hillenbrand M.   +12 more
europepmc   +1 more source

Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents. [PDF]

Pharmaceuticals (Basel)
Valsasina B, Orsini P, Terenghi C, Ocana A.   +3 more
europepmc   +1 more source

Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization [PDF]

, 1995
BARAM, TZ
core  

Accessory oligos for neuronal delivery of therapeutic siRNAs for ALS. [PDF]

Mol Ther Nucleic Acids
Rossi JJ.
europepmc   +1 more source

First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge. [PDF]

mBio
Dussupt V, Jensen JL, Thomas PV, Mendez-Rivera L, Lal KG, Zemil McCrea M, Swafford I, Hernandez J, Sankhala RS, Rao M, Arora J, Hajduczki A, Jian N, Rees PA, Showell-De Leon I, Smith G, Smith L, Wasson D, Schmid A, Teng I-T, Zhou T, Kwong PD, Currier JR, Reiley WW, Paquin-Proulx D, Polonis VR, Collins ND, Michael NL, Joyce MG, Krebs SJ.   +29 more
europepmc   +1 more source

Development and Prospects of Furin Inhibitors for Therapeutic Applications. [PDF]

Int J Mol Sci
Ivachtchenko AV, Khvat AV, Shkil DO.
europepmc   +1 more source

FDA-Approved HIV-1 Capsid Inhibition With Lenacapavir: A Paradigm Shift in Pre-exposure Prophylaxis. [PDF]

Cureus
Sanaullah K, Hasan AH, Abid MA.
europepmc   +1 more source